September 28th, 2015


U.S. pharmaceutical company sues Canadian Government Review Board regarding medication pricing which may directly impact the cost of all medications in Canada. To learn more about this story, please visit the following links:


Alexion Pharmaceuticals Challenges Ottawa's Ability To Control Patent Drug Prices


Maker of $700K-a-year drug challenging Canada's right to regulate prices


Voice your concerns to The Honourable Rona Ambrose MP, Minister of Health:

Website Designed and Hosted by The Social Business